Notice of Annual General Meeting
October 28, 2020
Notice is hereby given that the 108th Annual General Meeting of Pharmaceutical Defence Limited will be a Microsoft Teams Meeting on Thursday, the 19th of
Notice is hereby given that the 108th Annual General Meeting of Pharmaceutical Defence Limited will be a Microsoft Teams Meeting on Thursday, the 19th of
PDL is aware that most community pharmacies and hospitals supply or encounter dosage administration aids (DAAs). Despite their purpose to enhance compliance and minimise dosage
PDL has spoken with many pharmacists impacted by the changes to S3 supply requirements for salbutamol inhalers made by TGA earlier this year. These changes
A reminder to pharmacy proprietors of their key responsibilities Meridian Lawyers regularly assists a range of healthcare professionals to understand the legal and professional obligations
The PDL Professional Officers often see incident reports or regulatory notifications involving high risk medications such as S8 items and benzodiazepines. These incidents can involve
THE FOLLOWING VACANCIES WILL OCCUR AS OF THE DATE OF THE NEXT ANNUAL GENERAL MEETING TO BE HELD ON 19th NOVEMBER 2020 One Director for the State of Queensland One Director for
Advice for health practitioners and organisations It is trite advice to Australian health practitioners to say that they must exercise caution when dealing with their
PREDNISOLONE Prednisolone is overrepresented in incident reports to PDL for a variety of reasons. Errors often occur when the 5 mg and 25 mg strengths
The Pharmaceutical Defence Limited General Meeting will be a virtual meeting held on Thursday, 30 July 2020 at 11.00am (AEST). This meeting has been called
The recent experiences of pharmacists dealing with the challenges of the COVID-19 pandemic will help to inform practice into the future. One aspect of practice